Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marsh & Mclennan Companies (MRSH) EBT (2016 - 2025)

Marsh & Mclennan Companies (MRSH) has disclosed EBT for 17 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 4.66% year-over-year to $1.1 billion, compared with a TTM value of $5.5 billion through Dec 2025, up 1.08%, and an annual FY2025 reading of $5.5 billion, up 1.08% over the prior year.
  • EBT was $1.1 billion for Q4 2025 at Marsh & Mclennan Companies, up from $1.0 billion in the prior quarter.
  • Across five years, EBT topped out at $1.9 billion in Q1 2024 and bottomed at $613.0 million in Q4 2022.
  • Average EBT over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2021.
  • The sharpest move saw EBT surged 77.96% in 2021, then plummeted 36.21% in 2022.
  • Year by year, EBT stood at $961.0 million in 2021, then tumbled by 36.21% to $613.0 million in 2022, then surged by 70.96% to $1.0 billion in 2023, then dropped by 3.72% to $1.0 billion in 2024, then rose by 4.66% to $1.1 billion in 2025.
  • Business Quant data shows EBT for MRSH at $1.1 billion in Q4 2025, $1.0 billion in Q3 2025, and $1.6 billion in Q2 2025.